Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.57 is 46% above its 5-year average of -1.06, near the high end of its 5-year range (-2.58–-0.48).
68.07% above its 12-month average of -1.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-07-31): -0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 32 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.57
EARNINGS PER SHARE (EPS) AVG TTM
-1.79
EARNINGS PER SHARE (EPS) AVG 3Y
-1.21
EARNINGS PER SHARE (EPS) AVG 5Y
-1.06
EARNINGS PER SHARE (EPS) AVG 10Y
-0.71
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+68.07%
CURRENT VS 3Y AVG
+52.80%
CURRENT VS 5Y AVG
+46.31%
CURRENT VS 10Y AVG
+20.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Nutriband Inc.
Market Cap
$81.57M
Earnings Per Share (EPS)
-0.57
TTM Avg
-1.79
3Y Avg
-1.21
5Y Avg
-1.06
Market Cap
$81.84M
Earnings Per Share (EPS)
-1.51
TTM Avg
-0.45
3Y Avg
-0.34
5Y Avg
-0.27
Market Cap
$81.88M
Earnings Per Share (EPS)
-16.89
TTM Avg
-9.93
3Y Avg
-18.45
5Y Avg
-23.93
Market Cap
$80.90M
Earnings Per Share (EPS)
-1.88
TTM Avg
-2.06
3Y Avg
-2.07
5Y Avg
-1.66
Market Cap
$82.19M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.76
3Y Avg
-0.68
5Y Avg
-1.48
Market Cap
$82.69M
Earnings Per Share (EPS)
-0.22
TTM Avg
-0.23
3Y Avg
-0.23
5Y Avg
-0.24
Market Cap
$83.24M
Earnings Per Share (EPS)
-0.60
TTM Avg
-0.82
3Y Avg
-0.86
5Y Avg
-0.88
Market Cap
$79.29M
Earnings Per Share (EPS)
-0.11
TTM Avg
-3.20
3Y Avg
-6.52
5Y Avg
-6.93
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $81.57M | -0.57 | -1.79 | -1.21 | -1.06 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $81.84M | -1.51 | -0.45 | -0.34 | -0.27 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.88M | -16.89 | -9.93 | -18.45 | -23.93 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | -1.88 | -2.06 | -2.07 | -1.66 |
| Humacyte, Inc. (HUMA)vs › | $82.19M | -0.51 | -0.76 | -0.68 | -1.48 |
| MediciNova, Inc. (MNOV)vs › | $82.69M | -0.22 | -0.23 | -0.23 | -0.24 |
| LENSAR Inc (LNSR)vs › | $83.02M | N/A | -2.80 | -2.22 | -2.13 |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | -0.60 | -0.82 | -0.86 | -0.88 |
| vTv Therapeutics Inc. (VTVT)vs › | $79.29M | -0.11 | -3.20 | -6.52 | -6.93 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.61M | -1.18 | -4.40 | -32.48 | -54.06 |
Trailing EPS (TTM)
$-0.57
Forward EPS (Est.)
$1.57
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-01-31 | -2.58 |
| 2025-01-31 | -0.99 |
| 2024-01-31 | -0.69 |
| 2023-01-31 | -0.57 |
| 2022-01-31 | -1.06 |
| 2021-01-31 | -0.48 |
| 2020-01-31 | -0.44 |
| 2019-01-31 | -0.53 |
| 2018-01-31 | -0.48 |
| 2017-01-31 | -0.03 |
| 2016-01-31 | 0.00 |
